0001415889-22-000748.txt : 20220125 0001415889-22-000748.hdr.sgml : 20220125 20220125160542 ACCESSION NUMBER: 0001415889-22-000748 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220121 FILED AS OF DATE: 20220125 DATE AS OF CHANGE: 20220125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Norkunas Matthew CENTRAL INDEX KEY: 0001816836 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39319 FILM NUMBER: 22553977 MAIL ADDRESS: STREET 1: C/O GENERATION BIO CO. STREET 2: 301 BINNEY STREET, SUITE 401 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Generation Bio Co. CENTRAL INDEX KEY: 0001733294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 814301281 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-529-5908 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 form4-01252022_040114.xml X0306 4 2022-01-21 0001733294 Generation Bio Co. GBIO 0001816836 Norkunas Matthew C/O GENERATION BIO CO., 301 BINNEY ST CAMBRIDGE MA 02142 false true false false CHIEF FINANCIAL OFFICER Stock Option (right to buy) 6.49 2022-01-21 4 A 0 119000 0 A 2032-01-21 Common Stock 119000 119000 D Restricted Stock Units 2022-01-21 4 A 0 59500 0 A Common Stock 59500 59500 D This option was granted on January 21, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on January 21, 2023 and the remaining shares vesting in equal quarterly installments thereafter. Each restricted stock unit represents the right to receive one share of the company's common stock. The shares underlying the restricted stock units vest over two years, with 25% of the shares vesting on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. /s/ Jennifer Elliott, Attorney-in-Fact 2022-01-25